Cargando…

ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Patients with implantable cardioverter defibrillator (ICD) receiving appropriate ICD-shocks are known to have a worse prognosis. We recently developed a new treatment concept for ICD-patients with appropriate ICD shock, the ToVAM...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleemann, T, Lampropoulou, E, Kouraki, K, Strauss, M, Mohammad, O, Wenz, A, Zahn, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207566/
http://dx.doi.org/10.1093/europace/euad122.415
_version_ 1785046485480505344
author Kleemann, T
Lampropoulou, E
Kouraki, K
Strauss, M
Mohammad, O
Wenz, A
Zahn, R
author_facet Kleemann, T
Lampropoulou, E
Kouraki, K
Strauss, M
Mohammad, O
Wenz, A
Zahn, R
author_sort Kleemann, T
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Patients with implantable cardioverter defibrillator (ICD) receiving appropriate ICD-shocks are known to have a worse prognosis. We recently developed a new treatment concept for ICD-patients with appropriate ICD shock, the ToVAMI protocol consisting of the following three steps: Trigger optimization, Ventricular Arrhythmia treatment and Medical and Interventional prognostic heart failure treatment. This protocol was implemented into clinical practice since 9/2018. Aim of the study was to evaluate the impact of the ToVAMI protocol on the outcome of patients with first appropriate ICD shock. METHODS AND RESULTS: A total of 255 consecutive patients of a prospective single-centre ICD-registry who received a first appropriate ICD shock between 2012 and 8/2022 were analyzed. Patients with first ICD shock between 2012 and 8/2018 (control group, n = 175) were compared to patients with first ICD shock between 9/2018 and 6/2021 who were treated according to the ToVAMI protocol (ToVAMI group n = 80). Prospective use of the ToVAMI approach increased the rate of identified triggers (42% vs. 60%), VA therapy (34% vs. 51%), and tripled the rate of optimised heart failure treatment (Table 1). Patients treated according to the ToVAMI protocol had better survival without recurrent ICD shock (73% versus 55% at two years, p = 0.02) (Figure 1). The number of recurrent ICD shocks decreased from 48% to 25% after two years (p = 0.01), and all-cause mortality showed a trend towards lower mortality after two years (19% versus 10%, p = 0.32). In a multivariate analysis adjusting for 10 parameters, the ToVAMI approach was independently associated with a lower combined endpoint of mortality and repeated ICD shocks. CONCLUSION: The use of ToVAMI in patients with first ICD shock is associated with a reduction of the combined endpoint of mortality and recurrence of appropriate ICD shocks. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10207566
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102075662023-05-25 ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome Kleemann, T Lampropoulou, E Kouraki, K Strauss, M Mohammad, O Wenz, A Zahn, R Europace 14.2 - Implantable Cardioverter-Defibrillator (ICD) FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Patients with implantable cardioverter defibrillator (ICD) receiving appropriate ICD-shocks are known to have a worse prognosis. We recently developed a new treatment concept for ICD-patients with appropriate ICD shock, the ToVAMI protocol consisting of the following three steps: Trigger optimization, Ventricular Arrhythmia treatment and Medical and Interventional prognostic heart failure treatment. This protocol was implemented into clinical practice since 9/2018. Aim of the study was to evaluate the impact of the ToVAMI protocol on the outcome of patients with first appropriate ICD shock. METHODS AND RESULTS: A total of 255 consecutive patients of a prospective single-centre ICD-registry who received a first appropriate ICD shock between 2012 and 8/2022 were analyzed. Patients with first ICD shock between 2012 and 8/2018 (control group, n = 175) were compared to patients with first ICD shock between 9/2018 and 6/2021 who were treated according to the ToVAMI protocol (ToVAMI group n = 80). Prospective use of the ToVAMI approach increased the rate of identified triggers (42% vs. 60%), VA therapy (34% vs. 51%), and tripled the rate of optimised heart failure treatment (Table 1). Patients treated according to the ToVAMI protocol had better survival without recurrent ICD shock (73% versus 55% at two years, p = 0.02) (Figure 1). The number of recurrent ICD shocks decreased from 48% to 25% after two years (p = 0.01), and all-cause mortality showed a trend towards lower mortality after two years (19% versus 10%, p = 0.32). In a multivariate analysis adjusting for 10 parameters, the ToVAMI approach was independently associated with a lower combined endpoint of mortality and repeated ICD shocks. CONCLUSION: The use of ToVAMI in patients with first ICD shock is associated with a reduction of the combined endpoint of mortality and recurrence of appropriate ICD shocks. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207566/ http://dx.doi.org/10.1093/europace/euad122.415 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 14.2 - Implantable Cardioverter-Defibrillator (ICD)
Kleemann, T
Lampropoulou, E
Kouraki, K
Strauss, M
Mohammad, O
Wenz, A
Zahn, R
ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
title ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
title_full ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
title_fullStr ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
title_full_unstemmed ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
title_short ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
title_sort icd patients with first appropriate icd shock: new treatment concept is associated with better outcome
topic 14.2 - Implantable Cardioverter-Defibrillator (ICD)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207566/
http://dx.doi.org/10.1093/europace/euad122.415
work_keys_str_mv AT kleemannt icdpatientswithfirstappropriateicdshocknewtreatmentconceptisassociatedwithbetteroutcome
AT lampropouloue icdpatientswithfirstappropriateicdshocknewtreatmentconceptisassociatedwithbetteroutcome
AT kourakik icdpatientswithfirstappropriateicdshocknewtreatmentconceptisassociatedwithbetteroutcome
AT straussm icdpatientswithfirstappropriateicdshocknewtreatmentconceptisassociatedwithbetteroutcome
AT mohammado icdpatientswithfirstappropriateicdshocknewtreatmentconceptisassociatedwithbetteroutcome
AT wenza icdpatientswithfirstappropriateicdshocknewtreatmentconceptisassociatedwithbetteroutcome
AT zahnr icdpatientswithfirstappropriateicdshocknewtreatmentconceptisassociatedwithbetteroutcome